Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
MEDICINE	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___.	O
Chief	O
Complaint:	O
fever,	O
facial	O
swelling	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
___	O
PMH	O
of	O
HTN,	O
Sweet	O
Syndrome,	O
AML	O
(on	O
decitabine	O
s/p	O
C19),	O
who	O
presented	O
to	O
___	O
with	O
fever,	O
and	O
facial	O
swelling	O
was	O
admitted	O
for	O
further	O
workup	O
As	O
per	O
review	O
___	O
records,	O
he	O
presented	O
on	O
___	O
and	O
had	O
described	O
intermittent	O
nausea/vomiting/fever,	O
so	O
had	O
UA	O
which	O
was	O
negative,	O
then	O
had	O
CT	O
A/P	O
which	O
revealed	O
new	O
bladder	O
tumor.	O
CBC	O
was	O
notable	O
for	O
normal	O
WBC	O
but	O
22%	O
bands.	O
Blood	O
cultures	O
were	O
drawn	O
and	O
are	O
NGTD.	O
CXR	O
without	O
infiltrate.	O
Today,	O
pt	O
explained	O
that	O
he	O
initially	O
had	O
vomiting	O
which	O
caused	O
him	O
to	O
seek	O
care	O
at	O
___.	O
He	O
noted	O
that	O
there	O
they	O
could	O
not	O
identify	O
a	O
cause	O
of	O
his	O
symptoms,	O
and	O
wanted	O
to	O
keep	O
him	O
for	O
observation	O
but	O
he	O
noted	O
that	O
he	O
was	O
eager	O
to	O
go	O
home	O
so	O
pressured	O
them	O
to	O
discharge	O
him.	O
He	O
was	O
aware	O
that	O
they	O
found	O
a	O
mass	O
on	O
the	O
bladder	O
for	O
which	O
he	O
was	O
supposed	O
to	O
followup	O
with	O
an	O
oncologist	O
He	O
noted	O
that	O
since	O
going	O
home	O
his	O
vomiting	O
resolved,	O
and	O
he	O
had	O
been	O
a	O
little	O
constipated	B-Constipation
but	O
fevers	O
were	O
ongoing.	O
He	O
noted	O
that	O
today	O
he	O
developed	O
swelling	O
of	O
b/l	O
cheeks	O
which	O
was	O
tender	O
to	O
touch	O
which	O
caused	O
him	O
concern.	O
He	O
noted	O
that	O
he	O
shaves	O
with	O
a	O
razor	O
but	O
did	O
not	O
___	O
himself	O
in	O
the	O
area.	O
He	O
otherwise	O
denied	O
sore	O
throat,	O
headache,	O
rhinorrhea,	O
chest	O
discomfort,	O
SOB,	O
cough,	O
nausea/vomiting/abdominal	O
pain.	O
He	O
did	O
endorse	O
dysuria	O
over	O
the	O
past	O
few	O
days	O
which	O
he	O
said	O
was	O
new.	O
He	O
denied	O
any	O
swelling/rash	O
aside	O
from	O
his	O
face.	O
He	O
said	O
this	O
swelling	O
differed	O
from	O
his	O
prior	O
sweets	O
flare	O
which	O
was	O
diffuse	O
on	O
back	O
and	O
extremities.	O
Denied	O
sick	O
contacts.	O
Past	O
Medical	O
History:	O
Sweet's	O
Syndrome	O
___	O
eventually	O
discharged	O
on	O
prednisone	O
taper)	O
AML	O
as	O
above	O
HTN	O
Social	O
History:	O
___	O
Family	O
History:	O
Both	O
sisters	O
had	O
breast	O
cancer	O
Physical	O
Exam:	O
ADMISSION	O
PHYSICAL	O
EXAM:	O
Vitals:	O
___	O
2300	O
Temp:	O
98.6	O
PO	O
BP:	O
160/96	O
HR:	O
106	O
RR:	O
20	O
O2	O
sat:	O
95%	O
O2	O
delivery:	O
Ra	O
GENERAL:	O
laying	O
in	O
bed,	O
has	O
swollen	O
cheeks,	O
in	O
NAD,	O
pleasant	O
EYES:	O
PERRLA,	O
anicteric	O
HEENT:	O
OP	O
difficult	O
to	O
assess	O
as	O
does	O
not	O
open	O
wide,	O
has	O
dry	O
MM,	O
has	O
tender	O
swelling	O
over	O
b/l	O
parotid	O
glands	O
with	O
palpable	O
subcutaneous	O
component	O
(like	O
the	O
side	O
of	O
a	O
golf	O
ball),	O
but	O
no	O
fluctuance	O
NECK:	O
supple,	O
has	O
+	O
warmth	O
on	O
both	O
sides	O
of	O
neck	O
but	O
faint	O
erythema	O
if	O
anything,	O
no	O
tenderness	O
LUNGS:	O
CTA	O
b/l	O
no	O
wheezes/rales/rhonchi,	O
normal	O
RR,	O
no	O
cough	O
CV:	O
regular	O
rate,	O
normal	O
distal	O
perfusion,	O
no	O
edema	O
ABD:	O
soft,	O
NT,	O
ND,	O
normoactive	O
BS,	O
no	O
rebound	O
or	O
guarding	O
GENITOURINARY:	O
no	O
foley	O
EXT:	O
no	O
deformity,	O
normal	O
muscle	O
bulk	O
SKIN:	O
has	O
faint	O
erythema	O
and	O
+	O
warmth/tenderness	O
over	O
b/l	O
parotid	O
glands,	O
has	O
diffuse	O
warmth	O
b/l	O
neck	O
NEURO:	O
AOx3,	B-Delirium
fluent	O
speech	O
ACCESS:	O
PIV	O
DISCHARGE	O
PHYSICAL:	O
97.7	O
145/85	O
92	O
19	O
96	O
RA	O
GENERAL:	O
NAD,	O
lying	O
in	O
bed	O
HEENT:	O
AT/NC,	O
EOMI,	O
no	O
further	O
swelling	O
along	O
the	O
mandible,	O
remains	O
without	O
any	O
erythema.	O
No	O
longer	O
tender	O
to	O
palpation.	O
CV:	O
RRR,	O
s1+s2	O
normal,	O
mild	O
grade	O
II/VI	O
systolic	O
murmur	O
appreciated	O
at	O
LUSB	O
LUNGS:	O
CTAB,	O
no	O
wheezing	O
or	O
rhonchi	O
ABD:	O
soft,	O
NT,	O
ND,	O
normoactive	O
BS,	O
no	O
rebound	O
or	O
guarding	O
EXT:	O
Pulses	O
present,	O
no	O
edema	O
SKIN:	O
Diffuse	O
papular	O
rash	O
on	O
back	O
with	O
background	O
of	O
erythema,	O
lacking	O
pustules	O
or	O
patches	O
NEURO:	O
AOx3,	B-Delirium
no	O
motor/sensory	O
deficits	O
elicited	O
ACCESS:	O
PIV	O
Pertinent	O
Results:	O
ADMISSION	O
LABS:	O
___	O
05:05PM	O
OTHER	O
BODY	O
FLUID	O
___	O
___	O
___	O
04:57PM	O
___	O
___	O
04:50PM	O
___	O
UREA	O
___	O
___	O
TOTAL	O
___	O
ANION	O
___	O
___	O
04:50PM	O
___	O
this	O
___	O
04:50PM	O
___	O
___	O
___	O
04:50PM	O
___	O
___	O
NUC	O
___	O
___	O
___	O
04:50PM	O
___	O
___	O
___	O
___	O
04:50PM	O
PLT	O
___	O
PLT	O
___	O
___	O
02:50PM	O
URINE	O
___	O
___	O
02:50PM	O
URINE	O
___	O
___	O
02:50PM	O
URINE	O
___	O
SP	O
___	O
___	O
02:50PM	O
URINE	O
___	O
___	O
___	O
___	O
02:50PM	O
URINE	O
___	O
___	O
TRANS	O
EPI-<1	O
___	O
02:50PM	O
URINE	O
___	O
DISCHARGE	O
LABS:	O
___	O
06:40AM	O
BLOOD	O
___	O
___	O
Plt	O
___	O
___	O
06:40AM	O
BLOOD	O
Plt	O
___	O
___	O
06:40AM	O
BLOOD	O
___	O
___	O
___	O
06:40AM	O
BLOOD	O
___	O
IMAGING:	O
___	O
___:	O
1.	O
No	O
acute	O
intracranial	O
process.	O
2.	O
___	O
paranasal	O
sinus	O
disease,	O
as	O
described	O
above.	O
___	O
CT	O
Neck	O
w/	O
contrast:	O
1.	O
Mild	O
thickening	O
of	O
the	O
bilateral	O
platysmas	O
muscles	O
with	O
adjacent	O
mild	O
haziness/stranding	O
of	O
the	O
fat	O
both	O
superfical	O
and	O
deep	O
to	O
the	O
muscle,	O
(right	O
greater	O
than	O
left)	O
may	O
be	O
due	O
to	O
cellulitis.	O
No	O
drainable	O
fluid	O
collection.	O
2.	O
___	O
degenerative	O
disease	O
of	O
the	O
cervical	O
spine	O
without	O
acute	O
fracture.	O
___	O
EEG:	O
This	O
is	O
a	O
normal	O
continuous	O
ICU	O
EEG	O
monitoring,	O
but	O
only	O
brief	O
periods	O
of	O
wakefulness	O
are	O
recorded.	O
There	O
are	O
no	O
pushbutton	O
activations	O
during	O
the	O
recording.	O
There	O
are	O
no	O
epileptiform	O
discharges	O
or	O
electrographic	O
seizures	O
present	O
on	O
this	O
recording.	O
___	O
CTA	O
Head	O
and	O
Neck:	O
1.	O
Major	O
intracranial	O
and	O
cervical	O
arteries	O
are	O
patent	O
without	O
significant	O
stenosis.	O
2.	O
Punctate	O
arteriosclerotic	O
calcifications	O
are	O
visualized	O
in	O
the	O
right	O
cervical	O
carotid	O
bifurcation	O
with	O
no	O
evidence	O
of	O
significant	O
stenosis	O
3.	O
Partially	O
limited	O
exam	O
due	O
to	O
patient	O
motion,	O
within	O
this	O
limit,	O
grossly	O
there	O
is	O
no	O
evidence	O
of	O
acute	O
intracranial	B-Intracranial_haemorrhage
process	O
or	O
hemorrhage.	B-Intracranial_haemorrhage
___	O
MRI	O
Brain:	O
1.	O
No	O
evidence	O
for	O
acute	O
intracranial	B-Intracranial_haemorrhage
hemorrhage	B-Intracranial_haemorrhage
or	O
infarction.	O
2.	O
Moderate	O
global	O
parenchymal	O
volume	O
loss	O
and	O
evidence	O
of	O
chronic	O
small	O
vessel	O
ischemic	O
disease.	O
3.	O
Multifocal	O
paranasal	O
sinus	O
disease,	O
as	O
detailed	O
above.	O
___	O
ECHO:	O
The	O
left	O
atrium	O
is	O
elongated.	O
No	O
atrial	O
septal	O
defect	O
is	O
seen	O
by	O
2D	O
or	O
color	O
Doppler.	O
The	O
estimated	O
right	O
atrial	O
pressure	O
is	O
___	O
mmHg.	O
There	O
is	O
mild	O
symmetric	O
left	O
ventricular	O
hypertrophy	O
with	O
normal	O
cavity	O
size.	O
There	O
is	O
mild	O
regional	O
left	O
ventricular	O
systolic	O
dysfunction	O
with	O
hypokinesis	O
of	O
the	O
apical	O
segments.	O
The	O
remaining	O
segments	O
contract	O
normally	O
(Quantitative	O
(biplane)	O
LVEF	O
=	O
47	O
%).	O
Right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal.	O
The	O
ascending	O
aorta	O
is	O
mildly	O
dilated.	O
The	O
aortic	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
(?#).	O
There	O
is	O
a	O
minimally	O
increased	O
gradient	O
consistent	O
with	O
minimal	O
aortic	O
valve	O
stenosis.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened.	O
There	O
is	O
no	O
mitral	O
valve	O
prolapse.	O
Trivial	O
mitral	O
regurgitation	O
is	O
seen.	O
There	O
is	O
moderate	O
pulmonary	O
artery	O
systolic	O
hypertension.	O
The	O
___	O
pulmonic	O
regurgitation	O
velocity	O
is	O
increased	O
suggesting	O
pulmonary	O
artery	O
diastolic	O
hypertension.	O
There	O
is	O
a	O
trivial/physiologic	O
pericardial	O
effusion.	O
IMPRESSION:	O
Mild	O
symmetric	O
left	O
ventricular	O
hypertrophy	O
with	O
normal	O
cavity	O
size	O
and	O
mild	O
regional	O
systolic	O
dysfunction	O
c/w	O
CAD	O
in	O
an	O
LAD	O
distribution	O
or	O
Takotsubo	O
cardiomyopathy.	O
Minimal	O
aortic	O
valve	O
stenosis.	O
Pulmonary	O
artery	O
diastolic	O
hypertension.	O
Moderate	O
pulmonary	O
artery	O
systolic	O
hypertension.	O
Compared	O
with	O
the	O
prior	O
study	O
(images	O
reviewed)	O
of	O
___,	O
apical	O
hypokinesis	O
is	O
now	O
identified.	O
There	O
is	O
now	O
pulmonary	O
artery	O
diastolic	O
hypertension	O
and	O
the	O
degree	O
of	O
pulmonary	O
artery	O
systolic	O
hypertension	O
has	O
increased.	O
___	O
CT	O
chest	O
w/o	O
con:	O
1.	O
Bibasilar	O
consolidations	O
with	O
adjacent	O
___	O
opacity	O
most	O
prominent	O
left	O
lower	O
lobe,	O
consistent	O
with	O
bacterial	O
pneumonia.	B-Lower_respiratory_tract_infection
2.	O
Decrease	O
in	O
size	O
of	O
a	O
small	O
___	O
nonhemorrhagic	O
pleural	O
effusion.	O
3.	O
Possible	O
soft	O
tissue	O
stranding	O
near	O
colonic	O
diverticula	O
adjacent	O
to	O
the	O
tail	O
of	O
pancreas,	O
incompletely	O
evaluated.	O
Suggest	O
clinical	O
correlation	O
with	O
symptoms.	O
MICRO:	O
___	O
2:50	O
pm	O
URINE	O
**FINAL	O
REPORT	O
___	O
URINE	O
CULTURE	O
(Final	O
___:	O
NO	O
GROWTH.	O
___:	O
Blood	O
Cx	O
x2:	O
NEGATIVE	O
___:	O
Legionella	O
Urinary	O
Antigen	O
-	O
Negative	O
___:	O
MONOSPOT-	O
Negative	O
___	O
Respiratory	O
Viral	O
Panel,	O
PCR:	O
NEGATIVE	O
___:	O
Blood	O
Cx:	O
NEGATIVE	O
___:	O
Blood	O
Cx	O
x2:	O
PND	O
___	O
9:00	O
pm	O
SPUTUM	O
Source:	O
Expectorated.	O
GRAM	O
STAIN	O
(Final	O
___:	O
<10	O
PMNs	O
and	O
>10	O
epithelial	O
cells/100X	O
field.	O
Gram	O
stain	O
indicates	O
extensive	O
contamination	O
with	O
upper	O
respiratory	O
secretions.	O
Bacterial	O
culture	O
results	O
are	O
invalid.	O
PLEASE	O
SUBMIT	O
ANOTHER	O
SPECIMEN.	O
RESPIRATORY	O
CULTURE	O
(Final	O
___:	O
TEST	O
CANCELLED,	O
PATIENT	O
CREDITED.	O
Immunofluorescent	O
test	O
for	O
Pneumocystis	O
jirovecii	O
(carinii)	O
(Final	O
___:	O
SPECIMEN	O
NOT	O
PROCESSED	O
DUE	O
TO:	O
IMPROPER	O
SPECIMEN	O
COLLECTION.	O
Induced	O
sputum	O
required.	O
PLEASE	O
SUBMIT	O
ANOTHER	O
SPECIMEN.	O
TEST	O
CANCELLED,	O
PATIENT	O
CREDITED.	O
Reported	O
to	O
and	O
read	O
back	O
by	O
___	O
___	O
(___)	O
@	O
1103	O
___.	O
FUNGAL	O
CULTURE	O
(Preliminary):	O
GRAM	O
STAIN	O
OF	O
THIS	O
SPECIMEN	O
INDICATES	O
CONTAMINATION	O
WITH	O
OROPHARYNGEAL	O
SECRETIONS	O
AND	O
INVALIDATES	O
RESULTS	O
Specimen	O
is	O
only	O
screened	O
for	O
Cryptococcus	O
species.	O
New	O
specimen	O
is	O
recommended.	O
Brief	O
Hospital	O
Course:	O
___	O
PMH	O
of	O
HTN,	O
Sweet	O
Syndrome,	O
AML	O
(on	O
decitabine	O
s/p	O
C19),	O
who	O
presented	O
to	O
___	O
with	O
fever,	O
and	O
facial	O
swelling	O
found	O
to	O
have	O
multifocal	O
pneumonia.	B-Lower_respiratory_tract_infection
ACTIVE	O
MEDICAL	O
ISSUES	O
=====================	O
#Acute	O
hypoxic	O
respiratory	O
failure:	O
#Multifocal	O
PNA	B-Lower_respiratory_tract_infection
During	O
admission	O
patient	O
developed	O
next	O
oxygen	O
requirement	O
and	O
persistent	O
fever.	O
CXR	O
was	O
initially	O
concerning	O
for	O
volume	O
overload	O
and	O
he	O
was	O
treated	O
with	O
IV	O
Lasix	O
as	O
below.	O
CT	O
Chest	O
then	O
demonstrated	O
bilateral	O
multifocal	O
bacterial	O
PNA	B-Lower_respiratory_tract_infection
and	O
antibiotics	O
were	O
continued.	O
He	O
received	O
5	O
days	O
Azithromycin	O
and	O
5	O
days	O
concurrent	O
Vancomycin/Cefepime/Flagyl	O
before	O
transitioning	O
to	O
Cefepime	O
monotherpay.	O
His	O
oxygen	O
improved	O
and	O
he	O
was	O
weaned	O
from	O
supplemental	O
o2.	O
Viral	O
and	O
fungal	O
work	O
up	O
was	O
negative	O
(negative	O
Influenza,	O
RVP	O
antigen	O
and	O
PCR	O
panel,	O
urine	O
legionella,	O
strep	O
pneumo,	O
monospot,	O
___,	O
galactomannan).	O
He	O
was	O
transitioned	O
to	O
PO	O
Levofloxacin	O
to	O
complete	O
a	O
total	O
14	O
day	O
course	O
(on	O
___	O
for	O
pneumonia	B-Lower_respiratory_tract_infection
after	O
discussion	O
with	O
___	O
attending.	O
#	O
HFp/rEF.	O
In	O
the	O
setting	O
of	O
hypoxia	O
and	O
CXR	O
demonstrating	O
volume	O
overload,	O
TTE	O
was	O
performed	O
which	O
demonstrated	O
new	O
apical	O
hypokinesis,	O
EF	O
47%.	O
Cardiology	O
was	O
consulted	O
given	O
newly	O
depressed	O
EF.	O
Upon	O
___	O
the	O
TTE	O
and	O
overall	O
clinical	O
improvement,	O
cardiology	O
did	O
not	O
feel	O
that	O
additional	O
work	O
up	O
was	O
necessary	O
to	O
evaluate	O
for	O
CHF.	O
Mild	O
depression	O
in	O
EF	O
was	O
likely	O
exacerbated	O
in	O
the	O
setting	O
of	O
iatrogenic	O
volume	O
overload,	O
acute	O
illness,	O
and	O
poorly	O
controlled	O
HTN.	O
he	O
was	O
initially	O
treated	O
with	O
IV	O
Lasix	O
and	O
transitioned	O
to	O
PO	O
Lasix	O
20mg	O
daily	O
for	O
volume	O
management.	O
Home	O
___	O
was	O
continued.	O
Weight	O
on	O
the	O
day	O
of	O
discharge	O
was	O
98.6kg	O
217.37lbs.	O
He	O
will	O
have	O
PCP	O
follow	O
up	O
and	O
with	O
outpatient	O
cardiologist	O
as	O
needed.	O
#	O
Word	O
finding	O
difficulty:	O
Patient	O
had	O
a	O
transient	O
episode	O
on	O
___	O
associated	O
with	O
increased	O
limb	O
motor	O
activity	O
in	O
mild	O
tic	O
like	O
fashion	O
and	O
work	O
finding	O
difficulty	O
without	O
anomia.	O
No	O
focal	O
deficits	O
were	O
noted.	O
Neurology	O
was	O
consulted	O
and	O
CODE	O
STROKE	O
was	O
called.	O
NCHCT,	O
CTA	O
and	O
MRI	O
brain	O
was	O
unremarkable.	O
Spot	O
EEG	O
monitoring	O
was	O
negative	O
for	O
seizure	B-Seizures
activity.	O
mental	O
status	O
improved.	O
Episode	O
was	O
not	O
thought	O
to	O
represent	O
acute	O
ischemic/embolic	O
stroke	O
event	O
or	O
seizure	O
and	B-Seizures
he	O
was	O
monitored	O
without	O
further	O
episodes	O
during	O
admission.	O
#	O
Facial	O
Swelling	O
#	O
Hx	O
of	O
sweets	O
syndrome	O
Patient	O
initially	O
presented	O
with	O
bilateral	O
facial	O
swelling.	O
CTA	O
Neck	O
in	O
the	O
___	O
demonstrated	O
bilateral	O
platysmal	O
swelling	O
consistent	O
with	O
cellulitis.	O
He	O
was	O
started	O
on	O
antibiotics	O
for	O
fevers,	O
possible	O
SSTI	O
in	O
the	O
setting	O
of	O
immunosuppression.	O
There	O
was	O
no	O
evidence	O
of	O
significant	O
skin	O
erythema.	O
Bilateral	O
cheek	O
swelling	O
improved	O
over	O
time	O
without	O
specific	O
intervention.	O
#	O
Rash	O
on	O
back.	O
Developed	O
during	O
inpatient.	O
Evaluated	O
by	O
Dermatology,	O
morphology	O
not	O
consistent	O
with	O
specific	O
etiology.	O
Reassuring	O
examination	O
with	O
skin	O
findings	O
thought	O
to	O
be	O
exacerbated	O
by	O
moisture	O
and	O
positioning	O
in	O
hospital	O
bed.	O
Advised	O
to	O
keep	O
area	O
clean	O
and	O
dry	O
and	O
to	O
monitor	O
for	O
any	O
progression	O
of	O
symptoms.	O
#	O
HTN.	O
Continued	O
home	O
lisinopril/amlodipine	O
after	O
resolution	O
of	O
___.	O
#	O
AML	O
(on	O
decitabine	O
s/p	O
C19).	O
Last	O
decitabine	O
given	O
end	O
of	O
___.	O
Continued	O
home	O
acyclovir	O
ppx.	O
CBC	O
w/	O
diff	O
daily	O
#	O
Bladder	O
Mass.	O
Identified	O
on	O
CT	O
A/P	O
on	O
___	O
at	O
___.	O
Urology	O
was	O
consulted,	O
reviewed	O
imaging	O
and	O
determined	O
no	O
acute	O
inpatient	O
management	O
was	O
needed.	O
He	O
will	O
have	O
follow	O
up	O
in	O
clinic	O
on	O
___	O
for	O
outpatient	O
cystoscopy	O
for	O
further	O
management.	O
TRANSITIONAL	O
ISSUES	O
===================	O
PCP	O
-	O
___	O
continued	O
monitoring	O
of	O
HTN	O
with	O
uptitration	O
of	O
medications	O
as	O
needed	O
-	O
Recommend	O
outpatient	O
cardiology	O
follow	O
up	O
given	O
inpatient	O
TTE	O
demonstrating	O
next	O
apical	O
hypokinesis,	O
EF	O
47%	O
-	O
Started	O
on	O
20mg	O
PO	O
Lasix	O
during	O
admission	O
given	O
pulmonary	O
edema	O
and	O
mildly	O
depressed	O
EF	O
on	O
TTE.	O
Discharge	O
weight	O
98.6kg	O
217.37lbs.	O
Assess	O
for	O
continued	O
need	O
in	O
the	O
outpatient	O
setting	O
with	O
repeat	O
Chem10	O
and	O
weight	O
trends.	O
-	O
Levofloxacin	O
to	O
be	O
continued	O
until	O
___	O
for	O
extended	O
course	O
of	O
treatment	O
for	O
hospital	O
acquired	O
pneumonia	B-Lower_respiratory_tract_infection
after	O
discussion	O
with	O
___	O
attending	O
inpatient	O
-	O
Urology	O
follow	O
up	O
with	O
Dr.	O
___	O
on	O
___	O
for	O
cystoscopy/biopsy	O
of	O
bladder	O
wall	O
thickening	O
seen	O
on	O
admission	O
CT	O
A/P.	O
Name	O
of	O
health	O
care	O
proxy:	O
___	O
___:	O
wife	O
Phone	O
number:	O
___	O
CODE	O
STATUS:	O
FULL	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Fluticasone	O
Propionate	O
NASAL	O
1	O
SPRY	O
NU	O
Q12H:PRN	O
allergy	O
symptoms	O
2.	O
Lisinopril	O
40	O
mg	O
PO	O
DAILY	O
3.	O
Ondansetron	O
8	O
mg	O
PO	O
Q8H:PRN	O
nausea	O
4.	O
Polyethylene	O
Glycol	O
17	O
g	O
PO	O
DAILY:PRN	O
constipation	B-Constipation
5.	O
Senna	O
8.6	O
mg	O
PO	O
BID:PRN	O
constipation	B-Constipation
6.	O
amLODIPine	O
5	O
mg	O
PO	O
DAILY	O
7.	O
Acyclovir	O
400	O
mg	O
PO	O
Q8H	O
Discharge	O
Medications:	O
1.	O
Furosemide	O
20	O
mg	O
PO	O
DAILY	O
RX	O
*furosemide	O
20	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
daily	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
2.	O
Levofloxacin	O
750	O
mg	O
PO	O
DAILY	O
Duration:	O
8	O
Days	O
Continue	O
taking	O
until	O
___	O
RX	O
*levofloxacin	O
750	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
daily	O
Disp	O
#*8	O
Tablet	O
Refills:*0	O
3.	O
Acyclovir	O
400	O
mg	O
PO	O
Q8H	O
4.	O
amLODIPine	O
5	O
mg	O
PO	O
DAILY	O
5.	O
Fluticasone	O
Propionate	O
NASAL	O
1	O
SPRY	O
NU	O
Q12H:PRN	O
allergy	O
symptoms	O
6.	O
Lisinopril	O
40	O
mg	O
PO	O
DAILY	O
7.	O
Ondansetron	O
8	O
mg	O
PO	O
Q8H:PRN	O
nausea	O
8.	O
Polyethylene	O
Glycol	O
17	O
g	O
PO	O
DAILY:PRN	O
constipation	B-Constipation
9.	O
Senna	O
8.6	O
mg	O
PO	O
BID:PRN	O
constipation	B-Constipation
Discharge	O
Disposition:	O
Home	O
Discharge	O
Diagnosis:	O
Primary	O
Diagnosis	O
Multifocal	O
pneumonia	B-Lower_respiratory_tract_infection
Secondary	O
Diagnosis	O
Hypertension	O
Facial	O
swelling	O
History	O
of	O
sweets	O
syndrome	O
History	O
of	O
AML	O
Discharge	O
Condition:	O
Mental	B-Delirium
Status:	B-Delirium
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
Dear	O
Mr.	O
___,	O
It	O
was	O
a	O
pleasure	O
taking	O
care	O
of	O
you	O
during	O
your	O
hospitalization.	O
Briefly,	O
you	O
were	O
admitted	O
with	O
neck	O
swelling	O
and	O
fevers.	O
Your	O
neck	O
swelling	O
improved.	O
Your	O
oxygen	O
level	O
dropped	O
and	O
you	O
were	O
started	O
on	O
antibiotics.	O
A	O
CT	O
scan	O
of	O
your	O
chest	O
showed	O
a	O
bacterial	O
pneumonia.	B-Lower_respiratory_tract_infection
You	O
were	O
treated	O
with	O
IV	O
antibiotics	O
and	O
transitioned	O
to	O
oral	O
antibiotics	O
at	O
the	O
time	O
of	O
discharge.	O
Your	O
breathing	O
improved	O
and	O
you	O
no	O
longer	O
needed	O
oxygen.	O
You	O
were	O
seen	O
by	O
the	O
Dermatologists	O
for	O
the	O
skin	O
rash	O
on	O
your	O
back	O
and	O
should	O
try	O
to	O
keep	O
your	O
back	O
dry.	O
Please	O
continue	O
to	O
take	O
your	O
antibiotics	O
as	O
prescribed	O
and	O
follow	O
up	O
with	O
your	O
providers	O
as	O
listed.	O
We	O
wish	O
you	O
the	O
best,	O
Your	O
___	O
Care	O
Team	O
Followup	O
Instructions:	O
___	O

